Ara
Toplam kayıt 1, listelenen: 1-1
HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study
(MDPI, 2023)
This study aims to prepare a novel breast cancer-targeted micelle-based nanocarrier,
which is stable in circulation, allowing intracellular drug release, and to investigate its cytotoxicity,
apoptosis, and cytostatic ...